1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Austria Pharmaceuticals and Healthcare Report Q3 2016

Austria Pharmaceuticals and Healthcare Report Q3 2016

  • May 2016
  • -
  • Business Monitor International
  • -
  • 65 pages

Includes 3 FREE quarterly updates

BMI View: GDP growth in Austria is forecast to accelerate to 1.8% in 2016 and 1.9% in 2017, afterexpanding by a moderate 0.6% over the past four years. This modest recovery comes after a long period ofnear-stagnation; Austria's economy grew by just 2.9% between 2008 and 2015. We believe pharmaceuticalspending will post modest growth over the medium term as the government links growth in publichealthcare expenditure with nominal GDP growth. Overall, we view the Austrian pharmaceutical andhealthcare market as relatively stable and insulated from sudden downgrades.

Headline Expenditure Projections

- Pharmaceuticals: EUR6.44bn (USD7.09bn) in 2015 to EUR6.55bn (USD7.01bn) in 2016; 1.7% in localcurrency terms and -1.1% in US dollar terms. Forecasts in USD terms slightly decreased from theprevious quarter.

- Healthcare: EUR37.3bn (USD41.1bn) in 2015 to EUR38.8bn (USD41.5bn) in 2016; +3.8% in localcurrency terms and 1% in US dollar terms. Forecasts in USD terms slightly decreased from the previousquarter.

Table Of Contents

Austria Pharmaceuticals and Healthcare Report Q3 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Austria 2014-2020) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Austria 2012-2020) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2012-2020) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2012-2020) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Austria 2012-2020) 16
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Austria 2012-2020) 18
Patented Drug Market Forecast 19
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Austria 2012-2020) 20
Generic Drug Market Forecast 21
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Austria 2012-2020) 23
OTC Medicine Market Forecast 24
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Austria 2012-2020) 25
Pharmaceutical Trade Forecast 26
Table: Pharmaceutical Trade Data And Forecasts (Austria 2014-2020) 27
Table: Pharmaceutical Trade Data And Forecasts local currency (Austria 2014-2020) 27
Industry Risk/Reward Index 28
Western Europe Risk/Reward Index 28
Austria Risk/Reward Index 33
Rewards 33
Risks 33
Regulatory Review 35
Intellectual Property Issues 37
Pricing Regime 37
Reimbursement Regime 38
Market Overview 40
Healthcare Sector 41
Table: Healthcare Resources (Austria 2010-2015) 42
Table: Healthcare Personnel (Austria 2010-2015) 42
Table: Healthcare Activity (Austria 2010-2015) 43
Research And Development 43
Clinical Trials 44
Epidemiology 45
Competitive Landscape 47
Research-Based Industry 47
Table: Multinational Market Activity 48
Pharmaceutical Distribution 49
Table: Members Of ARGE Pharmazeutika, 2011 50
Pharmaceutical Retail Sector 51
Table: Pharmacy Outlets by Type, 2005-2009 52
Table: Pharmacy Outlets by State, 2005-2009 53
Demographic Forecast 54
Table: Population Headline Indicators (Austria 1990-2025) 55
Table: Key Population Ratios (Austria 1990-2025) 55
Table: Urban/Rural Population and Life Expectancy (Austria 1990-2025) 56
Table: Population By Age Group (Austria 1990-2025) 56
Table: Population By Age Group % (Austria 1990-2025) 57
Glossary 59
Methodology 61
Pharmaceutical Expenditure Forecast Model 61
Healthcare Expenditure Forecast Model 61
Notes On Methodology 62
Risk/Reward Index Methodology 63
Index Overview 64
Table: Pharmaceutical Risk/Reward Index Indicators 64
Indicator Weightings 65

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.